JP4861560B2 - 糖尿病合併症治療剤 - Google Patents

糖尿病合併症治療剤 Download PDF

Info

Publication number
JP4861560B2
JP4861560B2 JP2001041586A JP2001041586A JP4861560B2 JP 4861560 B2 JP4861560 B2 JP 4861560B2 JP 2001041586 A JP2001041586 A JP 2001041586A JP 2001041586 A JP2001041586 A JP 2001041586A JP 4861560 B2 JP4861560 B2 JP 4861560B2
Authority
JP
Japan
Prior art keywords
group
compound
methyl
diabetic
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP2001041586A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002241270A5 (enExample
JP2002241270A (ja
Inventor
征男 宮川
健志 渡辺
リュー バン
昌司 山田
啓仁 鈴木
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meiji Co Ltd
Original Assignee
Meiji Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to JP2001041586A priority Critical patent/JP4861560B2/ja
Application filed by Meiji Co Ltd filed Critical Meiji Co Ltd
Priority to AT02712380T priority patent/ATE492274T1/de
Priority to CA2438506A priority patent/CA2438506C/en
Priority to PCT/JP2002/001291 priority patent/WO2002066023A1/en
Priority to EP02712380A priority patent/EP1368013B1/en
Priority to ES02712380T priority patent/ES2355891T3/es
Priority to US10/467,063 priority patent/US7838565B2/en
Priority to DE60238666T priority patent/DE60238666D1/de
Publication of JP2002241270A publication Critical patent/JP2002241270A/ja
Publication of JP2002241270A5 publication Critical patent/JP2002241270A5/ja
Application granted granted Critical
Publication of JP4861560B2 publication Critical patent/JP4861560B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/713—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups a keto group being part of a six-membered ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
    • C07C403/06—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by singly-bound oxygen atoms
    • C07C403/08—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by singly-bound oxygen atoms by hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/51—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition
    • C07C45/511—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of singly bound oxygen functional groups to >C = O groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/56—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds
    • C07C45/57—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom
    • C07C45/59—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom in five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/673—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP2001041586A 2001-02-19 2001-02-19 糖尿病合併症治療剤 Expired - Lifetime JP4861560B2 (ja)

Priority Applications (8)

Application Number Priority Date Filing Date Title
JP2001041586A JP4861560B2 (ja) 2001-02-19 2001-02-19 糖尿病合併症治療剤
CA2438506A CA2438506C (en) 2001-02-19 2002-02-15 Use of a cyclohexenone derivatives in the manufacture of a medicament for treating diabetic complications
PCT/JP2002/001291 WO2002066023A1 (en) 2001-02-19 2002-02-15 Use of a cyclohexenone derivatives in the manufacture of a medicament for treating diabetic complications
EP02712380A EP1368013B1 (en) 2001-02-19 2002-02-15 Cyclohexenone derivative for treating diabetic neuropathy
AT02712380T ATE492274T1 (de) 2001-02-19 2002-02-15 Cyclohexenon derivate zur behandlung der diabetischen neuropathie
ES02712380T ES2355891T3 (es) 2001-02-19 2002-02-15 Derivado de ciclohexanona para el tratamiento de la neuropatía diabética.
US10/467,063 US7838565B2 (en) 2001-02-19 2002-02-15 Use of cyclohexenone derivatives in the manufacture of a medicament for treating diabetic complications
DE60238666T DE60238666D1 (de) 2001-02-19 2002-02-15 Cyclohexenon derivate zur behandlung der diabetischen neuropathie

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001041586A JP4861560B2 (ja) 2001-02-19 2001-02-19 糖尿病合併症治療剤

Publications (3)

Publication Number Publication Date
JP2002241270A JP2002241270A (ja) 2002-08-28
JP2002241270A5 JP2002241270A5 (enExample) 2006-06-22
JP4861560B2 true JP4861560B2 (ja) 2012-01-25

Family

ID=18904008

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001041586A Expired - Lifetime JP4861560B2 (ja) 2001-02-19 2001-02-19 糖尿病合併症治療剤

Country Status (8)

Country Link
US (1) US7838565B2 (enExample)
EP (1) EP1368013B1 (enExample)
JP (1) JP4861560B2 (enExample)
AT (1) ATE492274T1 (enExample)
CA (1) CA2438506C (enExample)
DE (1) DE60238666D1 (enExample)
ES (1) ES2355891T3 (enExample)
WO (1) WO2002066023A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2519178C (en) * 2003-03-28 2010-01-12 Meiji Dairies Corporation Process for producing cyclohexenone long-chain alcohols
CN101065119B (zh) * 2004-11-25 2010-08-25 明治乳业株式会社 肾功能不全的改良剂
CN101180041B (zh) * 2005-01-18 2011-04-13 明治乳业株式会社 感觉障碍治疗剂
US20080312336A1 (en) * 2005-05-26 2008-12-18 Keisuke Satoh Preventive and/or Therapeutic Agent for Diabetic Vascular Disorder and Respiratory Disorder
JP4986505B2 (ja) * 2005-05-26 2012-07-25 株式会社明治 糖尿病性血管障害および呼吸障害予防および／または治療剤
US8309611B2 (en) * 2010-09-20 2012-11-13 Golden Biotechnology Corporation Methods and compositions for treating lung cancer
US20130172424A1 (en) * 2011-12-30 2013-07-04 Golden Biotechnology Corporation Methods and compositions for treating diabetes
BR112018014841B1 (pt) 2016-01-22 2022-03-03 Taiho Pharmaceutical Co., Ltd. Álcoois de cadeia longa cicloexenona, seus usos e métodos para a produção dos mesmos com alta pureza

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69313316T2 (de) 1992-02-07 1998-02-19 Mitsubishi Gas Chemical Co Verwendung von Oxazopyrrolochinolinen und Pyrrolochinolonchinonen zur Herstellung von Produktionsbeschleunigern von Nervenwachstumsfaktoren g
US6113947A (en) * 1997-06-13 2000-09-05 Genentech, Inc. Controlled release microencapsulated NGF formulation
DE69811905T2 (de) * 1997-08-13 2003-11-06 Meiji Milk Products Co. Ltd., Tokio/Tokyo Cyclohexenon langketten alkohol und diese enthaltendes arzneimittel
JP4469441B2 (ja) 1999-02-10 2010-05-26 明治乳業株式会社 神経変性疾患の予防又は治療薬
US20040115810A1 (en) * 2000-10-04 2004-06-17 Bang Luu Stem cell differentiation-inducing promoter
JP3836684B2 (ja) * 2001-02-19 2006-10-25 明治乳業株式会社 排尿障害治療剤
WO2002094252A1 (en) * 2001-05-24 2002-11-28 Meiji Dairies Corporation Preventive or remedy for diseases caused by cerebrovascular disturbances

Also Published As

Publication number Publication date
WO2002066023A1 (en) 2002-08-29
EP1368013B1 (en) 2010-12-22
US7838565B2 (en) 2010-11-23
ATE492274T1 (de) 2011-01-15
EP1368013A1 (en) 2003-12-10
JP2002241270A (ja) 2002-08-28
DE60238666D1 (de) 2011-02-03
CA2438506A1 (en) 2002-08-29
CA2438506C (en) 2010-04-20
US20040102527A1 (en) 2004-05-27
ES2355891T3 (es) 2011-04-01

Similar Documents

Publication Publication Date Title
JP3766591B2 (ja) シクロヘキセノン長鎖アルコール及びこれを含有する医薬
JP2001515058A5 (enExample)
JP3836684B2 (ja) 排尿障害治療剤
JP4861560B2 (ja) 糖尿病合併症治療剤
EP0012643A2 (fr) Dérivés de la phényl-1 (pipéridyl-4)-3 propanone-1, procédés pour leur préparation, et médicaments les contenant
JP4469441B2 (ja) 神経変性疾患の予防又は治療薬
EP1322748B1 (en) Stem cell differentiation-inducing promoter
JP2002068973A (ja) 幹細胞分化誘導促進剤
EP1627866B1 (en) Carboxylic acid compound and medicine containing the same
JP4986505B2 (ja) 糖尿病性血管障害および呼吸障害予防および／または治療剤
WO2006126295A1 (ja) 糖尿病性血管障害および呼吸障害予防および／または治療剤
JPH0330565B2 (enExample)
JPH10511657A (ja) ３，３−（二置換）シクロヘキサン−１−オン二量体および関連化合物
HK1085198A (en) Carboxylic acid compound and medicine containing the same
JPH10316700A (ja) Ｄ−ホモ−１７−オキサ−１，３，５（１０）−エストラトリエン誘導体

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060501

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20060501

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20060502

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080201

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110621

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110822

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20111101

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20111107

R150 Certificate of patent or registration of utility model

Ref document number: 4861560

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20141111

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20141111

Year of fee payment: 3

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313114

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20141111

Year of fee payment: 3

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term